TY - CHAP
T1 - Photobiomodulation Therapy for Stroke
AU - Salehpour, Farzad
AU - Sadigh-Eteghad, Saeed
AU - Mahmoudi, Javad
AU - Kamari, Farzin
AU - Cassano, Paolo
AU - Hamblin, Michael Richard
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2023
Y1 - 2023
N2 - This chapter delves into the potential of photobiomodulation (PBM) therapy for stroke, providing an overview of the condition, discussing relevant animal models, and examining the therapeutic approach in both animal studies and human clinical trials. Section 1 introduces stroke, a leading cause of death and disability worldwide. The chapter discusses acute and chronic stroke (1.1), stroke-induced aphasia (1.2), and various animal models of stroke (1.3) that are crucial for understanding the disorder’s underlying mechanisms and testing potential therapeutic interventions, such as PBM. Section 2 focuses on PBM therapy for stroke, with subsections discussing its application in animal models (2.1) and human studies (2.3). This section provides a comprehensive overview of the current state of research, highlighting the potential benefits of PBM therapy in promoting neuroprotection, reducing brain damage, and enhancing functional recovery.
AB - This chapter delves into the potential of photobiomodulation (PBM) therapy for stroke, providing an overview of the condition, discussing relevant animal models, and examining the therapeutic approach in both animal studies and human clinical trials. Section 1 introduces stroke, a leading cause of death and disability worldwide. The chapter discusses acute and chronic stroke (1.1), stroke-induced aphasia (1.2), and various animal models of stroke (1.3) that are crucial for understanding the disorder’s underlying mechanisms and testing potential therapeutic interventions, such as PBM. Section 2 focuses on PBM therapy for stroke, with subsections discussing its application in animal models (2.1) and human studies (2.3). This section provides a comprehensive overview of the current state of research, highlighting the potential benefits of PBM therapy in promoting neuroprotection, reducing brain damage, and enhancing functional recovery.
UR - http://www.scopus.com/inward/record.url?scp=85169025886&partnerID=8YFLogxK
U2 - 10.1007/978-3-031-36231-6_11
DO - 10.1007/978-3-031-36231-6_11
M3 - Chapter
AN - SCOPUS:85169025886
T3 - Synthesis Lectures on Biomedical Engineering
SP - 221
EP - 258
BT - Synthesis Lectures on Biomedical Engineering
PB - Springer Nature
ER -